In recent years, RNA molecules, with the ability to affect or turn off pathogenic genes, have become promising drug candidates in several areas. However, it has been a challenge to develop techniques to deliver the RNA molecules ...
Apr 14, 2020
0
59
(HealthDay)—Adults who receive a provider recommendation for COVID-19 vaccination are more likely to have received one or more doses of COVID-19 vaccine, according to research published in the Dec. 17 issue of the U.S. ...
Dec 17, 2021
0
40
Many cancer drugs approved by the European Medicines Agency (EMA) between 1995 and 2020 lack proof of added benefit, particularly those approved through expedited ("fast track") pathways, finds a study published by The BMJ.
Feb 28, 2024
0
36
The burden of suboptimally controlled cardiovascular (CV) risk factors and incident risk of stroke and myocardial infarction (MI) are considerable in patients with head and neck squamous cell carcinoma (HNSCC), according ...
Jun 29, 2023
0
0
In utero exposure to commonly prescribed antipsychotic medications does not seem to meaningfully increase the risk for neurodevelopmental disorders (NDD) in offspring, according to a study published online March 28 in JAMA ...
Mar 31, 2022
0
17
(HealthDay)—Group, telephone, and guided self-help cognitive behavioral therapy (CBT) formats are as effective as individual CBT for adult depression, according to research published online April 17 in JAMA Psychiatry.
Apr 19, 2019
0
24
Scientists from the Precision Cardiology Lab (PCL) of the Broad Institute of MIT and Harvard and Bayer have generated detailed maps of a variety of cell types in the heart that are involved in two major causes of heart failure: ...
Jun 23, 2022
0
118
(HealthDay)—For patients with type 1 diabetes, resistance exercise is associated with a smaller initial decline in blood glucose compared with aerobic exercise, but offers a more prolonged reduction in post-exercise glycemia, ...
Dec 5, 2012
0
1
Drug combinations used for the treatment of non-small-cell lung cancer (NSCLC) and melanoma aren't as effective as they could be. Oncologists haven't had the right tools to predict drug interactions, other than in costly ...
Feb 21, 2019
0
25
A Swedish research team has published a new protocol with the potential for industrial-scale production of the brain helper cells known as astrocytes. Their work could help medical science develop treatments for such diseases ...
Feb 16, 2018
0
107
